CCR5 and cancer: CCR5 is commonly regarded as a core coreceptor for the entry of human immunodeficiency virus (HIV), and CCR5 antagonists such as Maraviroc have been widely used for HIV treatment.[58] However, the role of CCR5 signaling in cancer is still controversial.